Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|September 16, 2009
Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700)Jeffrey B Locke, Mark Hilgers, Karen Joy ShawAntimicrobial Agents and Chemotherapy|October 7, 2009
Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical originJeffrey B Locke, Mark Hilgers, Karen Joy ShawBioorganic & Medicinal Chemistry Letters|July 2, 2008
Identification of novel inhibitors of methionyl-tRNA synthetase (MetRS) by virtual screeningJohn Finn, Mark Stidham, Mark Hilgers, et al.Journal of Structural Biology|April 30, 2003
A fully integrated protein crystallization platform for small-molecule drug discoveryDavid Hosfield, John Palan, Mark Hilgers, et al.The Journal of Biological Chemistry|October 30, 2004
Conformational flexibility in crystal structures of human 11beta-hydroxysteroid dehydrogenase type I provide insights into glucocorticoid interconversion and enzyme regulationDavid J Hosfield, Yiqin Wu, Robert J Skene, et al.Antimicrobial Agents and Chemotherapy|September 15, 2010
Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3Jeffrey B Locke, Gracia Morales, Mark Hilgers, et al.Antimicrobial Agents and Chemotherapy|September 15, 2010
Structure-activity relationships of diverse oxazolidinones for linezolid-resistant Staphylococcus aureus strains possessing the cfr methyltransferase gene or ribosomal mutationsJeffrey B Locke, John Finn, Mark Hilgers, et al.Bioorganic & Medicinal Chemistry Letters|August 12, 2011
Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolinesXiaoming Li, Mark Hilgers, Mark Cunningham, et al.Pageof 1